Major Force in the Subcutaneous Drug Delivery Devices Market 2025: Rising Prevalence Of Diabetes And Cardiovascular Diseases Boosts Growth In Subcutaneous Drug Delivery Device Market

How Will the Subcutaneous Drug Delivery Devices Market Grow, and What Is the Projected Market Size?
The market size for subcutaneous drug delivery devices has experienced significant growth in recent years. The market, which is expected to expand from $27.66 billion in 2024 to $29.77 billion in 2025, projects an annual growth rate of 7.6%. This growth in the historical period is primarily due to an increase in chronic diseases prevalence, a greater need for drug self-administration, surging diabetes and obesity rates, a patient's inclination towards more convenient treatment options, and an increasing aging population.

The market size of subcutaneous drug delivery devices is predicted to witness considerable growth in the upcoming years. The market is expected to expand to $39.57 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period can be attributed to factors such as the expansion of the biologics and biosimilars market, increasing use of wearable drug delivery systems, the growth of personalized medicine, enhancements in healthcare reimbursement policies, and a heightened focus on home healthcare. Key trends anticipated throughout this period include the incorporation of digital health technologies, the production of intelligent and connected devices, the increased popularity of minimally invasive procedures, progress in needle-free injection systems, and the introduction of artificial intelligence in device development.

What Key Elements Are Boosting Growth in the Subcutaneous Drug Delivery Devices Market?
The escalating incidence of diabetes and cardiovascular diseases (CVD) is anticipated to boost the expansion of the subcutaneous drug delivery devices market in the future. Unhealthy eating habits, elderly populations, lack of physical activity, obesity, disparities in socio-economic status, stress, environmental factors, and insufficient availability of preventive healthcare services contribute to the growing prevalence of these diseases. Subcutaneous drug delivery devices are employed to manage these chronic diseases by offering a simple and controlled way to deliver insulin and other diabetes medications for blood glucose regulation, and drugs like anticoagulants or lipid-lowering agents in cardiovascular diseases. For example, new findings from the British Diabetic Association, a UK-based charity supporting people with diabetes, reveal that there are currently 4.3 million diagnosed diabetes cases in the UK as of April 2023. The number of registered diabetes cases for 2021-22 have surged by 148,951 compared to 2020-21, and over 2.4 million people are presently at high risk of developing type 2 diabetes in the UK. Furthermore, the Centers for Disease Control and Prevention, a US-based federal organization, reported in May 2024 that heart disease contributed to the death of 702,880 individuals in 2022, making up 1 in every 5 deaths. Consequently, the growing prevalence of diabetes and cardiovascular diseases (CVD) is propelling the expansion of the subcutaneous drug delivery devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp

Who Are the Major Industry Players Fueling Subcutaneous Drug Delivery Devices Market Expansion?
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

Which Key Developments Are Influencing the Subcutaneous Drug Delivery Devices Market?
In order to enhance the safety and precision of subcutaneous drug delivery, major firms in the market are concentrating their efforts on creating innovative new products such as small-scale digital liquid flow sensors, which can provide accurate, customizable flow sensors for large-volume injectors. These miniature digital liquid flow sensors are devices designed to accurately determine the flow rate of liquids in small applications, providing a digital output for precise monitoring and control. An example of such innovation is Sensirion AG, a Swiss company specializing in environmental and flow sensors. In May 2024, they introduced the SLD3x series sensor platform, featuring highly accurate digital liquid flow sensors with custom solutions, ensuring exact flow measurement, detecting occlusion, identifying in-line air bubbles, and monitoring liquid temperature. These miniature sensors are perfect for large-scale medical device production, securing optimal dosage and improved patient safety in subcutaneous drug delivery.

How Is the Segmentation of the Subcutaneous Drug Delivery Devices Market Defined?
The subcutaneous drug delivery devicesmarket covered in this report is segmented -

1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers

Subsegments:
1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) Pen Needles: Standard Pen Needles, Safety Pen Needles
3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report

What Is the Leading Region in the Subcutaneous Drug Delivery Devices Market?
North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Subcutaneous Drug Delivery Devices Global Market Report?

- Market Size Analysis: Analyze the Subcutaneous Drug Delivery Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Subcutaneous Drug Delivery Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Subcutaneous Drug Delivery Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Subcutaneous Drug Delivery Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19723

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.